Zosuquidar trihydrochloride

Zosuquidar trihydrochloride
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2005-12-15 00:00:00
Sponsor Kanisa Pharmaceuticals, Inc.;12264 El Camino Real;San Diego, California, 02130
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia